Answers are grounded in this paper and cite their sources.
Background Robotic-assisted hysterectomy is increasingly utilized for the surgical management of endometrial cancer. However, contemporary nationwide data evaluating practice patterns, sociodemographic disparities, and perioperative outcomes remain limited. This study evaluated national trends, predictors of robotic adoption, and perioperative outcomes compared with conventional laparoscopic hysterectomy using the National Inpatient Sample (NIS). Methods This retrospective cohort study utilized the NIS from 2016 through 2022. Adult hospitalizations for endometrial cancer undergoing minimally invasive hysterectomy were identified using ICD-10-CM/PCS codes and classified as robotic-assisted or conventional laparoscopic. Survey-specific discharge weights, clustering, and stratification were applied to generate nationally representative estimates. Temporal trends were examined using the Cochran-Armitage test, and independent predictors of robotic utilization and perioperative complications were evaluated using survey-weighted multivariable logistic regression. Results An estimated 47,900 weighted hospitalizations met the inclusion criteria (31,180 [65.1%] robotic-assisted; 16,720 [34.9%] conventional laparoscopic). The proportion of robotic-assisted procedures rose from 56.0% in 2016 to 74.2% in 2022 (P< 0.001). In multivariable models, robotic utilization was independently associated with younger age (aOR 0.92 per 10-year increase, 95% CI 0.90–0.94), higher household income (aOR 1.29 per one-quartile increase, 95% CI 1.26–1.31), private insurance (aOR 1.26, 95% CI 1.20–1.33 vs. Medicare), obesity (aOR 1.25, 95% CI 1.20–1.31), teaching hospitals (aOR 1.71, 95% CI 1.64–1.78), and large bed size (aOR 2.07, 95% CI 1.95–2.19). Non-White race was associated with lower odds of robotic utilization, including Black (aOR 0.54, 95% CI 0.51–0.58) and Hispanic hospitalizations (aOR 0.61, 95% CI 0.57–0.65) compared with White hospitalizations. After multivariable adjustment, robotic assistance remained independently associated with lower odds of experiencing any in-hospital perioperative complication (aOR 0.67, 95% CI 0.63–0.71; P<0.001). Unadjusted secondary endpoints demonstrated descriptive differences in open conversion (8.0% vs. 13.5%), non-home discharge (7.9% vs. 11.2%), and median length of stay (2.5 vs. 3.4 days), accompanied by higher median hospital charges ($80,316 vs. $69,829). Conclusion Robotic-assisted hysterectomy expanded substantially between 2016 and 2022 and was independently associated with fewer composite in-hospital complications. However, persistent socioeconomic and racial disparities highlight the need for targeted policies ensuring equitable access to advanced surgical technologies.
No takes yet. Share an insight, caveat, or question.
Alshaikh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: